There was strong disbelief when Tilray stated that they see an opening to the US once rescheduling happens:
"Why rescheduling could be boon to marijuana research
“I believe demand is going to skyrocket,” Richard Shain, CEO of Maridose, a DEA-licensed bulk manufacturer of cannabis, said in an interview with MJBizDaily.
Shain said Maridose is considering sourcing its starter materials from Canadian licensed producers through an import license issued by the DEA.
Because Canada allows exports of cannabis, it’s a good option for companies looking to stay compliant with DEA regulations, he said."
https://mjbizdaily.com/why-rescheduling-marijuana-could-be-boon-to-research/